uniQure completes comeback

Dutch gene therapy play uniQure N.V. (NASDAQ:QURE) is back on the public markets after a two-year hiatus. The company has taken advantage of renewed interest in gene therapy as well as the willingness of U.S. investors to invest in European companies.